Better designed vaccines for insect-spread viruses like dengue and Zika are likely after researchers discovered models of immature flavivirus particles were originally misinterpreted.
May 14, 2021
0
95
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. Designed ...
Nov 2, 2020
0
150
A research team led by scientists at the University of California, Riverside, has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host.
Aug 12, 2020
0
118
The premiere of the movie Scent of Mystery in 1960 marked a singular event in the annals of cinema: the first, and last, motion picture debut "in glorious Smell-O-Vision." Hoping to wow moviegoers with a dynamic olfactory ...
Jul 2, 2020
0
24
Scientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up the potential to target proteins of this family to combat cancer's diversity and ...
Sep 14, 2019
0
60
In a new study published in Proceedings of the National Academy of Sciences, researchers from the University of Colorado Denver and Binghamton University are the first to map the molecular structure and dynamics of an aggressive ...
May 17, 2019
0
131
An antibody taken from an Ebola survivor has been found to target all three human strains of the virus and could eventually lead to an all-purpose vaccine against the killer disease, scientists said Monday.
Mar 4, 2019
0
360
A research team at the Medical University of South Carolina (MUSC) has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors.
Feb 15, 2019
0
253
A Johns Hopkins University biologist is part of a research team that has demonstrated a way to size up a cell's resistance to radiation, a step that could eventually help improve cancer treatments.
Oct 18, 2017
0
3
As a molecular biologist, Kaori Noridomi gets an up-close view of the targets of her investigations. But when she began studying the molecular structures of a rarely diagnosed autoimmune disorder, myasthenia gravis, she decided ...
Jun 13, 2017
0
66
